These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35805133)

  • 1. Mucosal Plasma Cell Activation and Proximity to Nerve Fibres Are Associated with Glycocalyx Reduction in Diarrhoea-Predominant Irritable Bowel Syndrome: Jejunal Barrier Alterations Underlying Clinical Manifestations.
    Pardo-Camacho C; Ganda Mall JP; Martínez C; Pigrau M; Expósito E; Albert-Bayo M; Melón-Ardanaz E; Nieto A; Rodiño-Janeiro B; Fortea M; Guagnozzi D; Rodriguez-Urrutia A; Torres I; Santos-Briones I; Azpiroz F; Lobo B; Alonso-Cotoner C; Santos J; González-Castro AM; Vicario M
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations.
    Vicario M; González-Castro AM; Martínez C; Lobo B; Pigrau M; Guilarte M; de Torres I; Mosquera JL; Fortea M; Sevillano-Aguilera C; Salvo-Romero E; Alonso C; Rodiño-Janeiro BK; Söderholm JD; Azpiroz F; Santos J
    Gut; 2015 Sep; 64(9):1379-88. PubMed ID: 25209656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target?
    Xu XJ; Liu L; Yao SK
    J Zhejiang Univ Sci B; 2016 Jan; 17(1):1-9. PubMed ID: 26739521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Guilarte M; Vicario M; Martínez C; de Torres I; Lobo B; Pigrau M; González-Castro A; Rodiño-Janeiro BK; Salvo-Romero E; Fortea M; Pardo-Camacho C; Antolín M; Saperas E; Azpiroz F; Santos J; Alonso-Cotoner C
    Am J Gastroenterol; 2020 Dec; 115(12):2047-2059. PubMed ID: 32740086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.
    Martínez C; Vicario M; Ramos L; Lobo B; Mosquera JL; Alonso C; Sánchez A; Guilarte M; Antolín M; de Torres I; González-Castro AM; Pigrau M; Saperas E; Azpiroz F; Santos J
    Am J Gastroenterol; 2012 May; 107(5):736-46. PubMed ID: 22415197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.
    Guilarte M; Santos J; de Torres I; Alonso C; Vicario M; Ramos L; Martínez C; Casellas F; Saperas E; Malagelada JR
    Gut; 2007 Feb; 56(2):203-9. PubMed ID: 17005763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study.
    Xu XJ; Zhang YL; Liu L; Pan L; Yao SK
    Aliment Pharmacol Ther; 2017 Jan; 45(1):100-114. PubMed ID: 27862119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructure of intestinal mucosa in diarrhea-predominant irritable bowel syndrome.
    Zhao DY; Qi QQ; Long X; Li X; Chen FX; Yu YB; Zuo XL
    Physiol Int; 2019 Sep; 106(3):225-235. PubMed ID: 31560236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.
    Liu DR; Xu XJ; Yao SK
    World J Gastroenterol; 2018 Jan; 24(1):46-57. PubMed ID: 29358881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential mRNA Expression in Ileal Mucosal Biopsies of Patients With Diarrhea- or Constipation-Predominant Irritable Bowel Syndrome.
    Wang XJ; Carlson P; Chedid V; Maselli DB; Taylor AL; McKinzie S; Camilleri M
    Clin Transl Gastroenterol; 2021 Apr; 12(4):e00329. PubMed ID: 33843785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of corticotropin-releasing factor in intestinal mucosal eosinophils is associated with clinical severity in Diarrhea-Predominant Irritable Bowel Syndrome.
    Salvo-Romero E; Martínez C; Lobo B; Rodiño-Janeiro BK; Pigrau M; Sánchez-Chardi AD; González-Castro AM; Fortea M; Pardo-Camacho C; Nieto A; Expósito E; Guagnozzi D; Rodríguez-Urrutia A; de Torres I; Farré R; Azpiroz F; Alonso-Cotoner C; Santos J; Vicario M
    Sci Rep; 2020 Nov; 10(1):20706. PubMed ID: 33244004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome.
    Zhang Y; Qin G; Liu DR; Wang Y; Yao SK
    World J Gastroenterol; 2019 Jan; 25(2):269-281. PubMed ID: 30670915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study.
    Lobo B; Ramos L; Martínez C; Guilarte M; González-Castro AM; Alonso-Cotoner C; Pigrau M; de Torres I; Rodiño-Janeiro BK; Salvo-Romero E; Fortea M; Pardo-Camacho C; Guagnozzi D; Azpiroz F; Santos J; Vicario M
    United European Gastroenterol J; 2017 Oct; 5(6):887-897. PubMed ID: 29026603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome.
    Yu YB; Zuo XL; Zhao QJ; Chen FX; Yang J; Dong YY; Wang P; Li YQ
    Gut; 2012 May; 61(5):685-94. PubMed ID: 21997550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationship between adherens junction and tight junction and clinical symptoms in patients with diarrhea predominant irritable bowel syndrome].
    Zhang M; Chen CY; Hu Y; Lyu B
    Zhonghua Nei Ke Za Zhi; 2020 Jan; 59(1):40-46. PubMed ID: 31887835
    [No Abstract]   [Full Text] [Related]  

  • 17. [Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].
    Xu D; Chen W; Zhou WX; Wang CD; Fei GJ; Zhu LM; Xin HW; Zhong DR; Sun G; Fang XC
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2398-403. PubMed ID: 27545031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome.
    Yang J; Wang P; Liu T; Lin L; Li L; Kou G; Zhou R; Li P; Li Y
    BMC Microbiol; 2021 Nov; 21(1):316. PubMed ID: 34773967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome.
    Sundin J; Nordlander S; Eutamene H; Alquier-Bacquie V; Cartier C; Theodorou V; Le Nevé B; Törnblom H; Simrén M; Öhman L
    Neurogastroenterol Motil; 2019 Nov; 31(11):e13701. PubMed ID: 31518490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased TESK1-mediated cofilin 1 phosphorylation in the jejunum of IBS-D patients may explain increased female predisposition to epithelial dysfunction.
    Rodiño-Janeiro BK; Martínez C; Fortea M; Lobo B; Pigrau M; Nieto A; González-Castro AM; Salvo-Romero E; Guagnozzi D; Pardo-Camacho C; Iribarren C; Azpiroz F; Alonso-Cotoner C; Santos J; Vicario M
    Sci Rep; 2018 Feb; 8(1):2255. PubMed ID: 29396473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.